BioHarvest Sciences Inc.
CNVCF
OTC PK
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Revenue | 10.60M | 8.87M | 6.96M | 5.50M | 3.78M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 10.60M | 8.87M | 6.96M | 5.50M | 3.78M |
Cost of Revenue | 6.59M | 6.04M | 5.13M | 4.28M | 2.96M |
Gross Profit | 4.01M | 2.84M | 1.83M | 1.22M | 825.00K |
SG&A Expenses | 11.08M | 11.22M | 10.20M | 9.52M | 6.40M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 20.55M | 19.80M | 17.48M | 16.11M | 13.04M |
Operating Income | -9.95M | -10.92M | -10.51M | -10.61M | -9.26M |
Income Before Tax | -8.14M | -10.33M | -9.86M | -11.24M | -10.18M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -8.14 | -10.33 | -9.86 | -11.24 | -10.18 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -8.14M | -10.33M | -9.86M | -11.24M | -10.18M |
EBIT | -9.95M | -10.92M | -10.51M | -10.61M | -9.26M |
EBITDA | -9.26M | -10.25M | -9.86M | -10.02M | -8.72M |
EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
Average Basic Shares Outstanding | 1.85B | 1.84B | 1.82B | 1.81B | 1.82B |
Average Diluted Shares Outstanding | 1.85B | 1.84B | 1.82B | 1.81B | 1.82B |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |